Effects of antacids, ferrous sulfate, and ranitidine on absorption of DR-3355 in humans.

PubWeight™: 0.83‹?›

🔗 View Article (PMC 245488)

Published in Antimicrob Agents Chemother on October 01, 1992

Authors

K Shiba1, O Sakai, J Shimada, O Okazaki, H Aoki, H Hakusui

Author Affiliations

1: Second Department of Internal Medicine, Jikei University School of Medicine, Tokyo, Japan.

Articles by these authors

FK-506, a novel immunosuppressant isolated from a Streptomyces. II. Immunosuppressive effect of FK-506 in vitro. J Antibiot (Tokyo) (1987) 7.07

FK-506, a novel immunosuppressant isolated from a Streptomyces. I. Fermentation, isolation, and physico-chemical and biological characteristics. J Antibiot (Tokyo) (1987) 4.54

Cloning of a Streptococcus mutans glucosyltransferase gene coding for insoluble glucan synthesis. Infect Immun (1986) 4.08

Roles of bone morphogenetic protein type I receptors and Smad proteins in osteoblast and chondroblast differentiation. Mol Biol Cell (1999) 3.27

Electric-field-induced superconductivity in an insulator. Nat Mater (2008) 3.17

Epidemiological studies on patients with a persistent vegetative state. J Neurol Neurosurg Psychiatry (1977) 2.81

The oxazolidinone linezolid inhibits initiation of protein synthesis in bacteria. Antimicrob Agents Chemother (1998) 2.73

Serotypes VI and VIII predominate among group B streptococci isolated from pregnant Japanese women. J Infect Dis (1999) 2.50

A novel inhibitor of the STAT3 pathway induces apoptosis in malignant glioma cells both in vitro and in vivo. Oncogene (2006) 2.37

Discovery of FK-506, a novel immunosuppressant isolated from Streptomyces tsukubaensis. Transplant Proc (1987) 2.30

Mutations in the cardiac troponin I gene associated with hypertrophic cardiomyopathy. Nat Genet (1997) 2.20

Morphological and molecular characterization of adult cardiomyocyte apoptosis during hypoxia and reoxygenation. Circ Res (2000) 2.14

Dental pulp cells for induced pluripotent stem cell banking. J Dent Res (2010) 1.92

Discovery of superconductivity in KTaO₃ by electrostatic carrier doping. Nat Nanotechnol (2011) 1.89

Mechanism of action of 2, 3-butanedione 2-monoxime on contraction of frog skeletal muscle fibres. J Muscle Res Cell Motil (1988) 1.88

Cloning of a pH-sensitive K+ channel possessing two transmembrane segments. Nature (1994) 1.73

Reversal of anemia by erythropoietin therapy retards the progression of chronic renal failure, especially in nondiabetic patients. Nephron (1997) 1.63

Mechanism of renal excretion of AM-715, a new quinolonecarboxylic acid derivative, in rabbits, dogs, and humans. Antimicrob Agents Chemother (1983) 1.59

Prevalence and characteristics of shiga toxin-producing Escherichia coli from healthy cattle in Japan. Appl Environ Microbiol (2001) 1.58

Angiotensin II type1a receptor gene expression in the heart: AP-1 and GATA-4 participate in the response to pressure overload. Proc Natl Acad Sci U S A (1997) 1.56

Dental and facial bone abnormalities in pyknodysostosis: CT findings. AJNR Am J Neuroradiol (2007) 1.50

Bone marrow transplantation attenuates murine IgA nephropathy: role of a stem cell disorder. Kidney Int (1999) 1.50

Acute renal failure after binge drinking of alcohol and nonsteroidal antiinflammatory drug ingestion. Intern Med (1997) 1.45

Association between high serum alanine aminotransferase levels and more rapid development and higher rate of incidence of hepatocellular carcinoma in patients with hepatitis C virus-associated cirrhosis. Cancer (1999) 1.42

Pharmacokinetics and tolerance of DU-6859a, a new fluoroquinolone, after single and multiple oral doses in healthy volunteers. Antimicrob Agents Chemother (1995) 1.40

Characterization of homo- and heterodimerization of cardiac Csx/Nkx2.5 homeoprotein. J Biol Chem (2000) 1.39

A rare case of idiopathic hypoparathyroidism with varied neurological manifestations. Intern Med (1996) 1.39

Evaluation of in-vitro activity of new quinolones, macrolides, and minocycline against Mycoplasma pneumoniae. J Infect Chemother (2000) 1.38

Nocardicin A, a new monocyclic beta-lactam antibiotic. I. Discovery, isolation and characterization. J Antibiot (Tokyo) (1976) 1.35

A physical map with yeast artificial chromosome (YAC) clones covering 63% of the 12 rice chromosomes. Genome (2001) 1.35

Inducement of a heat-shock requirement for germination and production of increased heat resistance in Bacillus fastidiosus spores by manganous ions. J Bacteriol (1973) 1.34

Silencing mammalian target of rapamycin signaling by small interfering RNA enhances rapamycin-induced autophagy in malignant glioma cells. Oncogene (2006) 1.33

Transcriptional activation of urokinase by the Krüppel-like factor Zf9/COPEB activates latent TGF-beta1 in vascular endothelial cells. Blood (2000) 1.30

A novel monoclonal antibody (OPD4) recognizing a helper/inducer T cell subset. Its application to paraffin-embedded tissues. Am J Pathol (1989) 1.28

Role of the deletion of polymorphism of the angiotensin converting enzyme gene in the progression and therapeutic responsiveness of IgA nephropathy. J Clin Invest (1995) 1.27

Enantioselective disposition of ofloxacin in humans. Antimicrob Agents Chemother (1991) 1.25

Rapid identification and typing of Staphylococcus aureus by nested PCR amplified ribosomal DNA spacer region. FEMS Microbiol Lett (1997) 1.23

Angiotensin II and serum differentially regulate expression of cyclins, activity of cyclin-dependent kinases, and phosphorylation of retinoblastoma gene product in neonatal cardiac myocytes. Circ Res (1997) 1.21

Plasma brain natriuretic peptide concentrations predict survival after acute myocardial infarction. J Am Coll Cardiol (1996) 1.21

Prolongation of skin allograft survival in rats by a novel immunosuppressive agent, FK506. Transplantation (1988) 1.21

Isolation and characterization of the sucrose 6-phosphate hydrolase gene from Streptococcus mutans. Infect Immun (1986) 1.21

The role of C-C chemokines and their receptors in osteoarthritis. Arthritis Rheum (2001) 1.20

Studies on thiopeptin antibiotics. I. Characteristics of thiopeptin B. J Antibiot (Tokyo) (1970) 1.20

Studies on new phosphonic acid antibiotics. I. FR-900098, isolation and characterization. J Antibiot (Tokyo) (1980) 1.20

Depudecin induces morphological reversion of transformed fibroblasts via the inhibition of histone deacetylase. Proc Natl Acad Sci U S A (1998) 1.19

Detection of bcl-2 protein and bcl-2 messenger RNA in normal and neoplastic lymphoid tissues by immunohistochemistry and in situ hybridization. Blood (1992) 1.16

Cloning of the cDNA encoding human xanthine dehydrogenase (oxidase): structural analysis of the protein and chromosomal location of the gene. Gene (1993) 1.16

Renal handling of fleroxacin in rabbits, dogs, and humans. Antimicrob Agents Chemother (1990) 1.16

Everninomicin, a new oligosaccharide antibiotic: its antimicrobial activity, post-antibiotic effect and synergistic bactericidal activity. Drugs Exp Clin Res (1995) 1.15

Immunosuppressive effect of FK506 on collagen-induced arthritis in rats. Clin Immunol Immunopathol (1988) 1.15

Inhibition of the renal excretion of tazobactam by piperacillin. J Antimicrob Chemother (1994) 1.14

Clinical trial: dose-dependent therapeutic efficacy of acotiamide hydrochloride (Z-338) in patients with functional dyspepsia - 100 mg t.i.d. is an optimal dosage. Neurogastroenterol Motil (2010) 1.13

Synovial sarcoma of the hand. Skeletal Radiol (1997) 1.13

Angiotensin I converting enzyme gene polymorphism in non-insulin dependent diabetes mellitus. Kidney Int (1996) 1.12

Metabolic activation of CPT-11, 7-ethyl-10-[4-(1-piperidino)-1- piperidino]carbonyloxycamptothecin, a novel antitumor agent, by carboxylesterase. Biol Pharm Bull (1994) 1.12

Peptide bond synthesis: function of the efp gene product. Biol Chem (2000) 1.11

Inhibitory effect of cephalosporins on gamma-aminobutyric acid receptor binding in rat synaptic membranes. Antimicrob Agents Chemother (1985) 1.11

Thiopeptin, a new feed additive antibiotic: microbiological and chemical studies. Antimicrob Agents Chemother (1972) 1.11

Differential stereoselective pharmacokinetics of pantoprazole, a proton pump inhibitor in extensive and poor metabolizers of pantoprazole--a preliminary study. Chirality (1997) 1.10

Identification of two mutations in human xanthine dehydrogenase gene responsible for classical type I xanthinuria. J Clin Invest (1997) 1.09

Hepatitis C virus core protein activates the MAPK/ERK cascade synergistically with tumor promoter TPA, but not with epidermal growth factor or transforming growth factor alpha. Hepatology (2000) 1.09

CT evaluation of hepatic tumors: comparison of CT with arterial portography, CT with infusion hepatic arteriography, and simultaneous use of both techniques. AJR Am J Roentgenol (1995) 1.09

Durability of resin-dentin bonds. J Adhes Dent (1999) 1.09

Presence of pannus-like tissue on osteoarthritic cartilage and its histological character. Osteoarthritis Cartilage (2003) 1.09

Statistical mechanics of DNA topoisomers. The helical worm-like chain. J Mol Biol (1985) 1.08

Immunohistochemical detection of advanced glycosylation end-products in the peritoneum and its possible pathophysiological role in CAPD. Kidney Int (1997) 1.08

Fluorodeoxyglucose-positron-emission tomography imaging of head and neck squamous cell cancer. AJNR Am J Neuroradiol (2009) 1.08

[Epidermoid cyst of the testis: a report of 2 cases]. Hinyokika Kiyo (1988) 1.07

Studies on new phosphonic acid antibiotics. III. Isolation and characterization of FR-31564, FR-32863 and FR-33289. J Antibiot (Tokyo) (1980) 1.07

Enhancement of guanine-nucleotide exchange activity of C3G for Rap1 by the expression of Crk, CrkL, and Grb2. J Biol Chem (1997) 1.07

KF17837: a novel selective adenosine A2A receptor antagonist with anticataleptic activity. Eur J Pharmacol (1994) 1.06

Crystallization behavior and thermal properties of melt-crystallized poly[(R)-3-hydroxybutyric acid-co-6-hydroxyhexanoic acid] films. Int J Biol Macromol (1999) 1.06

Acute arterial thrombosis with antithrombin III deficiency in nephrotic syndrome: report of a case. Surg Today (2000) 1.05

Brain natriuretic peptide as a hormonal marker of ventricular diastolic dysfunction in children with Kawasaki disease. Pediatr Cardiol (2005) 1.04

Cardiovascular effects of ICI 118,587, a new beta-adrenoceptor partial agonist in man. Jpn Circ J (1986) 1.04

Purulent pericarditis due to group B streptococcus and mycotic aneurysm of the ascending aorta: case report. Jpn Circ J (2000) 1.03

Direct communication between the right pulmonary artery and the left atrium. A case report and review of the literature. J Thorac Cardiovasc Surg (1979) 1.03

Autophagy-inducing agents augment the antitumor effect of telerase-selve oncolytic adenovirus OBP-405 on glioblastoma cells. Gene Ther (2008) 1.03

erbB-2 overexpression but no activation of beta-Catenin gene in extramammary Paget's disease. J Invest Dermatol (1999) 1.03

Interlamellar waters in dimyristoylphosphatidylethanolamine-water system as studied by calorimetry and X-ray diffraction. Biochim Biophys Acta (1997) 1.03

Precancerous conditions of biliary tract cancer in patients with pancreaticobiliary maljunction: reappraisal of nationwide survey in Japan. J Hepatobiliary Pancreat Surg (2000) 1.02

Molecular characterization of a prokaryotic translation factor homologous to the eukaryotic initiation factor eIF4A. Int J Biochem Cell Biol (1999) 1.02

Improvement of treadmill capacity and collateral circulation as a result of exercise with heparin pretreatment in patients with effort angina. Circulation (1988) 1.02

Physical interaction between retinoic acid receptor and Sp1: mechanism for induction of urokinase by retinoic acid. Blood (1999) 1.01

Bicyclomycin, a new antibiotic. I. Taxonomy, isolation and characterization. J Antibiot (Tokyo) (1972) 1.01

High-performance liquid chromatographic determination of the new quinolone antibacterial agent DU-6859a in human serum and urine using solid-phase extraction with photolysis-fluorescence detection. J Chromatogr B Biomed Appl (1994) 1.01

Bacteriuria in a population-based cohort of women. J Infect Dis (1978) 1.00

Comparison of mechanism-based inhibition of human cytochrome P450 2C19 by ticlopidine, clopidogrel, and prasugrel. Xenobiotica (2009) 1.00

Protein tyrosine kinases expressed in glomeruli and cultured glomerular cells: Flt-1 and VEGF expression in renal mesangial cells. Biochem Biophys Res Commun (1995) 1.00

Antibody responses to the outer membrane protein P6 of non-typeable Haemophilus influenzae and pneumococcal capsular polysaccharides in otitis-prone children. Acta Otolaryngol (1999) 0.99

Factors controlling pulmonary vascular resistance in fetal lambs. J Pediatr (1965) 0.98

Clinical effects of acrylic resilient denture liners applied to mandibular complete dentures on the alveolar ridge. J Oral Rehabil (2007) 0.98

F-actin network may regulate a Cl- channel in renal proximal tubule cells. J Membr Biol (1993) 0.98

Immunosuppressive effect of FK506 on experimental allergic encephalomyelitis in rats. Int J Immunopharmacol (1988) 0.97

Regulatory functions of hapten-reactive helper and suppressor T lymphocytes. III. Amplification of a generation of tumor-specific killer T-lymphocyte activities by suppressor T-cell-depleted hapten-reactive T lymphocytes. J Exp Med (1979) 0.97

Progress in pursuit of therapeutic A2A antagonists: the adenosine A2A receptor selective antagonist KW6002: research and development toward a novel nondopaminergic therapy for Parkinson's disease. Neurology (2003) 0.97

Comparative simulation of excitation and body surface electrocardiogram with isotropic and anisotropic computer heart models. IEEE Trans Biomed Eng (1995) 0.97

Hydroxyapatite coating on Ti plate by a dipping method. Biomed Mater Eng (1995) 0.97